To: Carrie Gose | Columbus Business First
Post:
Has been updated:
COLUMBUS BUSINESS FIRST — Battelle and a team of two Central Ohio biotech startups provide critical scientific and manufacturing support to bring regenerative therapies for neurological diseases to market won a federal contract to provide
Battelle spin-off company AmplifyBio and biotechnology manufacturer Andelyn Biosciences Inc. are one of only three teams to bid for individual jobs over eight years in the National Institutes of Health’s up to $149 million program. Joined the research giant in Columbus. .
Greg Kimmel, vice president and general manager of Battelle’s Health business, said: “If we can be a part of bringing something like that to market, even if it’s not what we discovered, I think it’s a pretty big deal.”
For more on this story, visit ColumbusBusinessFirst.com.
